Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version).
10.3760/cma.j.cn112150-20201110-01353
- Collective Name:Chinese Preventive Medicine Association;Vaccine and Immunology Branch of the Chinese Preventive Medicine Association
- Publication Type:Review
- Keywords:
Consensus;
Immunoprophylaxis;
Pneumococcal conjugate vaccine;
Pneumococcal disease;
Pneumococcal polysaccharide vaccine;
Streptococcus pneumoniae
- MeSH:
Adult;
Child;
China;
Consensus;
Humans;
Pneumococcal Infections/prevention & control*;
Pneumococcal Vaccines;
Streptococcus pneumoniae;
Vaccines, Conjugate
- From:
Chinese Journal of Preventive Medicine
2020;54(12):1315-1363
- CountryChina
- Language:Chinese
-
Abstract:
Pneumococcal disease is a serious global public health problem and a leading cause of morbidity and mortality of children and adults in China. Antibiotics are commonly used to treat pneumococcal disease. However, antibiotic resistance to
